These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18672298)

  • 1. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.
    Hampton DW; Anderson J; Pryce G; Irvine KA; Giovannoni G; Fawcett JW; Compston A; Franklin RJ; Baker D; Chandran S
    J Neuroimmunol; 2008 Sep; 201-202():200-11. PubMed ID: 18672298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ; Lee J; Nikodemova M; Fabry Z; Duncan ID
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis.
    Holman SP; Lobo AS; Novorolsky RJ; Nichols M; Fiander MDJ; Konda P; Kennedy BE; Gujar S; Robertson GS
    Exp Neurol; 2020 Nov; 333():113430. PubMed ID: 32745471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse.
    Nishri Y; Fainstein N; Goldfarb S; Hampton D; Macrini C; Meinl E; Chandran S; Ben-Hur T
    J Neuroimmunol; 2021 Jul; 356():577582. PubMed ID: 33910137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Anderson JM; Hampton DW; Patani R; Pryce G; Crowther RA; Reynolds R; Franklin RJ; Giovannoni G; Compston DA; Baker D; Spillantini MG; Chandran S
    Brain; 2008 Jul; 131(Pt 7):1736-48. PubMed ID: 18567922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.
    Hampton DW; Serio A; Pryce G; Al-Izki S; Franklin RJ; Giovannoni G; Baker D; Chandran S
    Acta Neuropathol Commun; 2013 Dec; 1():84. PubMed ID: 24364862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
    Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
    J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.
    Tallantyre EC; Bø L; Al-Rawashdeh O; Owens T; Polman CH; Lowe J; Evangelou N
    Brain; 2009 May; 132(Pt 5):1190-9. PubMed ID: 19420101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis.
    Manrique-Hoyos N; Jürgens T; Grønborg M; Kreutzfeldt M; Schedensack M; Kuhlmann T; Schrick C; Brück W; Urlaub H; Simons M; Merkler D
    Ann Neurol; 2012 Feb; 71(2):227-44. PubMed ID: 22367995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing.
    Sevastou I; Pryce G; Baker D; Selwood DL
    PLoS One; 2016; 11(6):e0157754. PubMed ID: 27355629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.
    McGavern DB; Murray PD; Rodriguez M
    J Neurosci Res; 1999 Nov; 58(4):492-504. PubMed ID: 10533042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.